More Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-12-172.html
Description:
The National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) encourages NIH Research Demonstration and
Dissemination Project grant (R18) applications from institutions/
organizations to test practical, sustainable, acceptable, and cost efficient
adaptations of efficacious strategies or approaches prevent and treat
diabetes and/or obesity. Research must target the prevention or reversal of
obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes,
or the prevention or delay of the complications of these conditions. The
approaches tested should have the potential to be widely disseminated to
clinical practice, individuals and communities at risk.
A site to track announcements of diabetes related research opportunities.
Friday, November 30, 2012
Planning Grants for Translational Research to Improve Obesity and Diabetes Outcomes (R34)
More Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-12-173.html
Description:
The National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) and the National Institute of Mental Health (NIMH) encourage
NIH Clinical Trial Planning Grant Program grant (R34) applications from
institutions/ organizations to develop and pilot test practical, sustainable,
acceptable, and cost efficient adaptations of efficacious strategies or
approaches prevent and treat diabetes and/or obesity. Research must target
the prevention or reversal of obesity, prevention of type 2 diabetes,
improved care of type 1 and type 2 diabetes, or the prevention or delay of
the complications of these conditions. NIMH encourages research focused on people
with severe mental illness (SMI), whose risk for obesity and type 2 diabetes
is twice that of the general population. The approaches tested should have
the potential to be widely disseminated to clinical practice, individuals and
communities at risk.
Practical Interventions to Improve Medication Adherence in Primary Care (R01)
More Information:
http://grants.nih.gov/grants/guide/pa-files/PA-12-022.html
Description:
This FOA seeks Research Project Grant (R01) applications that propose practical interventions to improve adherence to medication. This FOA will support research to test interventions with the potential to significantly improve medication adherence in patients with chronic health conditions in settings where primary health care is delivered (including, dental and eye care settings). Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension) or multiple comorbid conditions (e.g., hypertension and HIV/AIDS). Studies should use the most rigorous design and methodology possible given the populations and settings in which the study is taking place. Primary outcomes of the research should include: a patient self-report of medication adherence, and at least one other non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.). In addition, applications should include a health outcome or biomarker (e.g., blood pressure, viral load in HIV patients, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. Researchers should address the capacity of the tested approach for wide dissemination, the sustainability of the approach once the research is concluded, and are encouraged to include measurement and costs of the intervention characteristics and contextual factors that affect implementation and adoption.
http://grants.nih.gov/grants/guide/pa-files/PA-12-022.html
Description:
This FOA seeks Research Project Grant (R01) applications that propose practical interventions to improve adherence to medication. This FOA will support research to test interventions with the potential to significantly improve medication adherence in patients with chronic health conditions in settings where primary health care is delivered (including, dental and eye care settings). Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension) or multiple comorbid conditions (e.g., hypertension and HIV/AIDS). Studies should use the most rigorous design and methodology possible given the populations and settings in which the study is taking place. Primary outcomes of the research should include: a patient self-report of medication adherence, and at least one other non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.). In addition, applications should include a health outcome or biomarker (e.g., blood pressure, viral load in HIV patients, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. Researchers should address the capacity of the tested approach for wide dissemination, the sustainability of the approach once the research is concluded, and are encouraged to include measurement and costs of the intervention characteristics and contextual factors that affect implementation and adoption.
Monday, November 26, 2012
Determinants and Consequences of Personalized Health Care and Prevention (U01)
Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-12-024.html
Description:
This Funding Opportunity Announcement (FOA) solicits U01 applications for economic research on the determinants and consequences of personalization in health care and prevention. The objective of the research program is to support foundational research on economic aspects of individualized health interventions that will provide a framework for subsequent applied analyses. Program Director(s)/Principal investigator(s) for projects funded under this FOA are required to participate in a Steering Committee that will help identify key strategies to support critical research advances in this field. Research to be supported by this FOA includes analyses and development of research tools to advance understanding of: factors that affect the value of personalized interventions to individuals and their families, health care providers and payers, and society at large; incentives and constraints facing individuals and their families, health care providers, research organizations, drug and device manufacturers, and others and how they affect the actual and optimal extent to which interventions are tailored to patients’ personal characteristics or preferences; and strategies to promote improvements in health and cost outcomes through personalization of health care and preventive interventions. The purpose of this FOA is to expand generalizable understanding of the determinants and consequences of personalization in health care and prevention; it is not primarily intended to support evaluation of specific interventions or strategies for addressing particular health conditions.
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-12-024.html
Description:
This Funding Opportunity Announcement (FOA) solicits U01 applications for economic research on the determinants and consequences of personalization in health care and prevention. The objective of the research program is to support foundational research on economic aspects of individualized health interventions that will provide a framework for subsequent applied analyses. Program Director(s)/Principal investigator(s) for projects funded under this FOA are required to participate in a Steering Committee that will help identify key strategies to support critical research advances in this field. Research to be supported by this FOA includes analyses and development of research tools to advance understanding of: factors that affect the value of personalized interventions to individuals and their families, health care providers and payers, and society at large; incentives and constraints facing individuals and their families, health care providers, research organizations, drug and device manufacturers, and others and how they affect the actual and optimal extent to which interventions are tailored to patients’ personal characteristics or preferences; and strategies to promote improvements in health and cost outcomes through personalization of health care and preventive interventions. The purpose of this FOA is to expand generalizable understanding of the determinants and consequences of personalization in health care and prevention; it is not primarily intended to support evaluation of specific interventions or strategies for addressing particular health conditions.
Tuesday, October 23, 2012
WU-Center for Diabetes Translation Research Pilot and Feasibility Grants
Description:
The Washington University Center for Diabetes Translation Research (WU-CDTR) is soliciting applications for its second round of Pilot & Feasibility grants. The Center will grant two awards for up to $25,000 per year for 1-2 years, for a total of $50,000 over two years for each award. A second year of funding is contingent on review of first year’s progress. This pilot does not provide money for indirect costs. Projects must be for translation research, preferably T3 or T4; community-based; and in the area of diabetes, prediabetes/metabolic syndrome, or obesity prevention or treatment in order to be considered responsive to this RFA. T3 research is the practice-oriented stage of translational science that relies on dissemination and implementation (research to find out how an intervention or program is actually used in the community or the world-at-large), and T4 research explores what is the best method to reach clinicians and patients alike with a nationwide policy concerning an intervention or program so that they will understand it and start to use it.
Letters of Intent (LOI) should be limited to 2 pages and include a brief description of the project, how it is community-based and how it relates to diabetes, prediabetes/metabolic syndrome or obesity prevention or treatment.
LOI is due by November 15, 2012. Funding will start August 1, 2013.
Full applications will be by invitation only. Formal applications are due by March 15, 2013 and should include a Research Plan in NIH format (Specific Aims, Significance, Innovation, Approach; limited to 5 pages), detailed budget and justification, and Biosketches and Other Support for all key personnel. Additional application guidelines will be included with official invitation to submit.
Eligibility: In order to be eligible for WU-CDTR pilot funding, PIs must be members of the WU-CDTR and have a PhD or MD. For information on becoming a member of the WU-CDTR please visit our website at http://cdtr.wustl.edu.
LOIs and applications should be sent to:
Jenn Hultz
jhultz@wustl.edu
(314) 935-7504
The Washington University Center for Diabetes Translation Research (WU-CDTR) is soliciting applications for its second round of Pilot & Feasibility grants. The Center will grant two awards for up to $25,000 per year for 1-2 years, for a total of $50,000 over two years for each award. A second year of funding is contingent on review of first year’s progress. This pilot does not provide money for indirect costs. Projects must be for translation research, preferably T3 or T4; community-based; and in the area of diabetes, prediabetes/metabolic syndrome, or obesity prevention or treatment in order to be considered responsive to this RFA. T3 research is the practice-oriented stage of translational science that relies on dissemination and implementation (research to find out how an intervention or program is actually used in the community or the world-at-large), and T4 research explores what is the best method to reach clinicians and patients alike with a nationwide policy concerning an intervention or program so that they will understand it and start to use it.
Letters of Intent (LOI) should be limited to 2 pages and include a brief description of the project, how it is community-based and how it relates to diabetes, prediabetes/metabolic syndrome or obesity prevention or treatment.
LOI is due by November 15, 2012. Funding will start August 1, 2013.
Full applications will be by invitation only. Formal applications are due by March 15, 2013 and should include a Research Plan in NIH format (Specific Aims, Significance, Innovation, Approach; limited to 5 pages), detailed budget and justification, and Biosketches and Other Support for all key personnel. Additional application guidelines will be included with official invitation to submit.
Eligibility: In order to be eligible for WU-CDTR pilot funding, PIs must be members of the WU-CDTR and have a PhD or MD. For information on becoming a member of the WU-CDTR please visit our website at http://cdtr.wustl.edu.
LOIs and applications should be sent to:
Jenn Hultz
jhultz@wustl.edu
(314) 935-7504
Interventions for Health Promotion and Disease Prevention in Native American Populations (R01) Research Project Grant
Additional Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-11-346.html
Description:
The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic disease, the consumption of tobacco, alcohol and other drugs, mental illness or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities. The long-term goal of this FOA is to reduce mortality and morbidity in NA communities. For the purposes of this FOA Native Americans include the following populations: Alaska Native, American Indian, and Native Hawaiian. The term ‘Native Hawaiian’ means any individual any of whose ancestors were natives, prior to 1778, of the area which now comprises the State of Hawaii.
http://grants.nih.gov/grants/guide/pa-files/PAR-11-346.html
Description:
The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic disease, the consumption of tobacco, alcohol and other drugs, mental illness or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities. The long-term goal of this FOA is to reduce mortality and morbidity in NA communities. For the purposes of this FOA Native Americans include the following populations: Alaska Native, American Indian, and Native Hawaiian. The term ‘Native Hawaiian’ means any individual any of whose ancestors were natives, prior to 1778, of the area which now comprises the State of Hawaii.
Monday, October 15, 2012
Small Grant Program for NIDDK K01/K08/K23 Recipients (R03)
Additional Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-12-285.html
Description:
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, and K23 recipients the opportunity to apply for Small Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, which allows up to $50,000 direct costs per year for each of two years, the NIDDK is seeking to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support a subsequent R01, or equivalent, application.
http://grants.nih.gov/grants/guide/pa-files/PAR-12-285.html
Description:
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, and K23 recipients the opportunity to apply for Small Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, which allows up to $50,000 direct costs per year for each of two years, the NIDDK is seeking to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support a subsequent R01, or equivalent, application.
Subscribe to:
Posts (Atom)